The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Whether it be for research, exploration, infrastructure, paying off debt or developing software – most ASX-listed small-cap companies engage in capital raising along the way.

The very reason many are publicly listed is to gain access to fresh capital.

What tends to accompany a successful capital raising, however, is a steep drop in the company’s share price.

To better understand why this happens and the pros and cons of capital raising, MD and Founder of Avanguard Capital, Patrick Kedemos joins the conversation to answer all things capital raising.

More From The Market Online
US flag

Dateline Resources pops +40% on Trump gov’t move to greenlight REE and gold mining

An injunction on ASX-listed Dateline Resources’ (ASX:DTR) California-based Colosseum REE and gold project appears set to be lifted after
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

ASX Today: XJO has a good day ahead of RBA rate call; AU bond sell-off continues

While we’re set to get the RBA’s next rate decision tomorrow – which all big bank analysts think is going to be a
Aussie cash

Northern Star jumps +7% on confirmed takeover rumour from Gold Fields Ltd

ASX-listed Northern Star Resources (ASX:NST) has confirmed reports in Bloomberg that it’s received a 100% takeover offer from a

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)